Chiesi launches pilot inhaler recycling scheme in the UK
Scheme will run for 12 months in the Leicester, Leicestershire and Rutland areas
Read More
Tag: inhaler
Boehringer to launch first reusable soft mist inhaler
Pharmacists are likely to see people with COPD and asthma more regularly than a GP or nurse, so they play a pivotal role in educating patients on their medicines and inhaler technique.
Read More
UK first EU nation to launch flutiform k-haler for asthma
Napp Pharmaceuticals says the UK is the first country in Europe to launch flutiform k-haler, a breath-actuate inhaler for adolescents and adults living with asthma.
Read More
AZ’ triple combo COPD inhaler hits PhIII targets
AstraZeneca recently unveiled top-line trial data backing use of an experimental triple combination therapy being developed for use with its Aerosphere technology in patients with chronic obstructive pulmonary disease (COPD).
Read More
Chiesi’s triple combo inhaler shows benefit in COPD
Chiesi has unveiled results of a late-stage study showing the superior efficacy of its triple combination inhaler for chronic obstructive pulmonary disease (COPD) compared with standard dual therapy.
Read More
GSK/Innoviva’s triple therapy hits targets in COPD trial
GlaxoSmithKline and Innoviva’s three-drug inhaler fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI) has come out on top in a trial assessing its effectiveness against the dual therapy Symbicort Turbohaler in patients with chronic obstructive pulmonary disorder (COPD).
Read More
- Tozorakimab shows significant benefit in two major COPD trials
- Daratumumab becomes first oncology injectable approved for patient administration
- Laigo Bio completes final close of €17m seed financing round
- Axplora announces expansion as newest part of $60m API investment programme
- DNA Script signs SYNTAX distribution agreements with Gencell, BMS and Biostream
